Pharma outsourcing: Benefits & challenges of integrated projects

摘要

In today's pharmaceutical industry, innovation and speed-to-market are more critical than ever. The life sciences industry is moving towards more complex molecules, niche therapy areas, targeted delivery - all of which require a wide range of expertise, capabilities, and scale, in both development and manufacturing, a number of which may not be present in-house. In parallel, there has been an increase in virtual biotech firms with a willingness to externalize clinical development and manufacturing to focus on their competencies and to reduce costs.